STOCK TITAN

SunOpta (NASDAQ: STKL) taken private at $6.50 cash per share

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

SunOpta Inc. is being taken private, and Oaktree-affiliated funds now report owning no shares. An amended Schedule 13D/A shows that, at the May 1, 2026 closing of an Arrangement, each common share of SunOpta was transferred to a purchaser for $6.50 in cash. Each share of Series B-1 Preferred Stock was exchanged into common shares using a 405.9555467-to-1 exchange rate, and each issued and outstanding Special Share, Series 2 was cancelled with no payment. After closing, SunOpta’s common shares ceased trading on NASDAQ and the company became privately held. The reporting Oaktree entities now disclose 0 shares and 0% beneficial ownership.

Positive

  • None.

Negative

  • None.

Insights

SunOpta is taken private at $6.50 per share, eliminating Oaktree’s reported stake.

The amendment describes the closing of an Arrangement under which each SunOpta common share was transferred to a purchaser for $6.50 in cash. Series B-1 Preferred Stock converted into common shares at a fixed 405.9555467 exchange rate before that cash-out.

Each Special Share, Series 2 was cancelled without payment, and SunOpta’s common shares ceased trading on NASDAQ, making the issuer privately held. Oaktree-related reporting entities now show 0 shares and 0% beneficial ownership, confirming their exit as a reporting shareholder after the transaction’s completion.

Cash consideration per common share $6.50 per share Consideration for each SunOpta common share at Arrangement closing
Series B-1 exchange rate 405.9555467 common shares per preferred share Exchange rate for Series B-1 Preferred Stock into common shares
Oaktree beneficial ownership 0.00 shares Aggregate amount beneficially owned by each reporting person after closing
Oaktree ownership percentage 0% Percent of SunOpta common class represented by Oaktree’s holdings post-closing
Arrangement closing date May 1, 2026 Date the transactions contemplated by the Arrangement were consummated
Series B-1 Preferred Stock financial
"each share of Series B-1 Preferred Stock was transferred to the Issuer in exchange"
Special Share, Series 2 financial
"each issued and outstanding Special Share, Series 2 was cancelled without any payment"
beneficially own regulatory
"After giving effect to Closing, the Reporting Persons ceased to beneficially own any Issuer securities."
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Arrangement regulatory
"In connection with consummation on May 1, 2026, of the transactions contemplated by the Arrangement"
An arrangement is a formal agreement or structured plan between two or more parties that spells out who will do what, when, and under what conditions for a transaction or ongoing relationship. For investors it matters because arrangements set the practical rules that drive cash flow, ownership, risk and timing—like a blueprint or recipe for how a deal will play out—so understanding them helps predict a company’s future value and potential surprises.
privately-held company financial
"Following Closing, the Common Shares ceased to be listed or traded on NASDAQ, and the Issuer became a privately-held company."





8676EP108

(CUSIP Number)
Richard Ting
Oaktree Capital Group Holdings GP, LLC, 333 South Grand Avenue, 28th Floor
Los Angeles, CA, 90071
(213) 830-6300

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
05/01/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Oaktree Organics, L.P.
Signature:/s/ Zachary Serebrenik
Name/Title:Zachary Serebrenik / Managing Director
Date:05/05/2026
Oaktree Huntington Investment Fund II, L.P.
Signature:/s/ Zachary Serebrenik
Name/Title:Zachary Serebrenik / Managing Director
Date:05/05/2026
Oaktree Capital Holdings, LLC
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Managing Director
Date:05/05/2026
Oaktree Capital Group Holdings GP, LLC
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Managing Director
Date:05/05/2026
Comments accompanying signature:
OAKTREE ORGANICS, L.P., By: Oaktree Fund GP, LLC Its: General Partner, By: Oaktree Fund GP I, L.P. Its: Managing Member. OAKTREE HUNTINGTON INVESTMENT FUND II, L.P., By: Oaktree Huntington Investment Fund II GP, L.P. Its: General Partner, By: Oaktree Fund GP, LLC Its: General Partner, By: Oaktree Fund GP, I, L.P. Its: Managing Member.

FAQ

What does the Schedule 13D/A Amendment No. 12 for SunOpta (STKL) disclose?

It discloses that an Arrangement closed on May 1, 2026, under which each SunOpta common share was transferred to a purchaser for $6.50 in cash. Following this closing, SunOpta became a privately held company and its common shares stopped trading on NASDAQ.

At what price were SunOpta (STKL) common shares cashed out in the transaction?

Each SunOpta common share was transferred to the purchaser for $6.50 in cash at the closing of the Arrangement. This cash consideration applied to all issued and outstanding common shares as part of the go-private transaction described in the amended Schedule 13D/A.

What happened to SunOpta’s Series B-1 Preferred Stock in this Arrangement?

Each share of Series B-1 Preferred Stock was transferred to SunOpta in exchange for common shares. The number of common shares was calculated by multiplying each preferred share by 405.9555467, the exchange rate contemplated by the terms of the Series B-1 Preferred Stock.

What was the treatment of SunOpta Special Share, Series 2 in the transaction?

Each issued and outstanding Special Share, Series 2 was cancelled without any payment. Holders of these Special Shares, Series 2, therefore did not receive cash or other consideration in connection with the Arrangement’s closing, according to the amended ownership filing.

Does Oaktree still beneficially own any SunOpta (STKL) securities after the closing?

No. The reporting Oaktree entities each report 0 shares and 0% beneficial ownership after giving effect to the closing. Rows 7–11 and 13 of their cover pages show zero voting power, zero dispositive power, and a zero aggregate amount of SunOpta common shares owned.

Is SunOpta (STKL) still traded on NASDAQ after this Arrangement?

No. Following the closing of the Arrangement, SunOpta’s common shares ceased to be listed or traded on NASDAQ. As a result, the issuer is now described as a privately held company, and its common equity is no longer available on public markets.